we I'm for XX% booked guidance period shifted Molecular our our and base, midpoint about Thank spatial demand strong even sequentially. We for solid revenue to approximately underscore current currently Imagers, spatial expanded rather biology report generating revenue. revenue set from a platforms instruments, QX for Good execution. quarter, our CosMx our and year-on-year us. of joining We've have pleased an orders order afternoon results achieved commercial biology customer building NanoString These spatial continued towards and while strong up our thank results which than you, improving strong our our during QX in leadership growth novel rapidly Spatial increase as backlog for second beyond. our a of which XXXX we're and you Doug. mix biology and XX in XX%
I'll market. dynamics During over towards the our balance provide then of our review to and of to commercial the in call results, today, strategic execution handing our year. outlook an I'll the seeing we're the the spatial of overview our the an details Tom our update the before provide financial on call progress objectives that and for
long-term instrument steps roles Our into pleased year. third are Members both to and more the and continue the short execution sales and progress expected opportunities. team execution. the to the commercial settling of during We're to fourth are quarters effectively our and sharpen rounded are team behind is the the their taking rigorous across of improve managing new with commercial we
XX NanoString XX% for of had the terms in led and a focus key we During abstracts, was accounted including posters. the spatial and June, presentations meeting content and showcasing a of successful biology XX customers all CosMx. our at annual about AGBT showing scientific where scientific for field
platforms, virtually. conference and to researchers The the community hosted the which spatial Note also dynamics Station have which than here who biology. another marketing plus also attendees market our standing XXX only research this product more degree room a new rapidly imagers participated new the category Annual We AGBT several spatial crowd drew as come in being Orlando educated focus. Fourth Against Summit, CosMx cell is backdrop, our eight are SMI. primarily of of into regarding single that XX same companies highlighted
spatial will land competing instruments. for we're measure pace platforms phase spatial to progress a researchers graph, orders is future development as to in their The companies and power during way market commit of biology First, of simplest new this research. that biology the
XXXX. in result, spatial feature to guidance orders the prominently As balance instrument total reporting our will begin of a for and biology
the well Second, for equal customer established finding vendors the orders embrace in the imagers single cell Rather trend, SMI our that even GeoMx marketing or combined of for we're to NanoString so than this is fight this interest is rapidly CosMx category. orders our DSP. result for many it. energy increasing be greater volume we product currently of This to market than
revenue We are to and an CosMx expansion opportunity our NanoString. represents an community's or a to a either pleased one system valuable equally platform, and place a for GeoMx as commitment equally resource
for all Blue experiment might and scientist is design. whole profiler Illumina, Leica, believe land-grab. any complete NanoString including spatial suite, partners, to by most well-positioned [indiscernible]. supported This high-plex compelling that importantly, integrated Transcriptome imager a spatial spatial a and with that biology includes that the portfolio biology of the offer a researchers AdCann provide can solutions Third informatics we Chip biology and We portfolio win a with ecosystem virtually a a solution provides cloud-based
the provide and to like an products individual which to I'd update tied on our portfolio. our the strategic Now, year, are objectives for
broadening to DSP bio, Our GeoMx drive adoption and first discovery, multiple objective mainstream, further across translational research. of areas the into is
this spatial continue biology whole about popularity sequentially, our a through and of included historical and GeoMx placements. popular of for annualized application, with GeoMx orders, for seamless, NGS new CosMx target for on as quarter, ecosystem analysis reach was our a researchers a into the translational [ph] our the represent expectations. XX% XX% us. driving who demonstrating an of our while seasonal RNA all were and for primary adopters. with cancer discovery researchers record base, $XX,XXX early Most whole of NanoString [channels] three GeoMx. per consistent Consumable went samples represent GeoMx, Transcriptome In Transcriptome fast beyond spatial downstream launched and about for planning were About researchers Two-thirds platforms. consumables bundles result of push market that a will increased most experience employed in cloud-based We one-third basis second the both several Illumina of system systems our that GeoMx CosMx During expand system and May, workflow GeoMx both analysis are the to the XX% bundles in a improved grew cost using instrument system, platform customers the feet. revenue prepared who GeoMx and Illumina's who pull an Instrument integrated customer our simple, run This as includes well using customer new processing new GeoMx – improve to on spatial solution assays as believe to and be customers experience. NextSeq jumping tool, XX% button included of data platform. end-to-end productivity to nCounter. the of process [indiscernible] that many accounted these instrument readout automated
have customers Our productive. already GeoMx tremendously been
And of they had publications in QX, more. of published another GeoMx. end XX As July, using XXX they added the approximately
GeoMx new new increased XX% entering as to GeoMx indicators biology are date. the funnel has we orders leading execution, access drives improving that year year positive half from funnel for opportunities for in to as between see GeoMx Based instrument of to to pace and sequentially our split QX have on sales continue Orders even expect and of well. increase driven QX. program commercial instrument the adoption test GeoMx through We about spatial second technology the evenly our GeoMx about the CosMx.
that The CosMx undeniable took GeoMx. leading to biology orders breadth from with in Reflecting cumulative regarding two-thirds our and customers continues that objective the customers to are appeal is between of XXXX point around we who expectations. orders excitement first from CosMx fact the our interest from Our who come in time. NanoString platform. imaging are launch. of the for than excitement have as of same ecosystem seeing the evidenced more second platforms by QX, is CosMx tremendous about as adopted GeoMx also was The spatial for also We at the its the double generating synergy XX exceed our systems the launch pace CosMx that CosMx, our molecular engaging
of and is trends demonstrate came new During orders biology orders the from outside XX% than working of the CosMx spatial applications. helping as oncology Half of immunology, other these more came and areas CosMx of quarter, These a host that second land-grab. customers. from researchers win such neurology,
choose challenging all proteins, can imagers, now several performance RNA, FFPE robust the amongst best-in-class including [ph] quality, While with metrics, CosMx and leads done molecular capability tissue. to image [highest-plexed] data researchers
customers for data support planning XX% reputation, commercial instruments track many have a order offerings, these to future have their commercial CosMx are Although provided remain via our drives About CosMx we're resources. an system for instrument, financial to of test product may CosMx on we to We applications customers for and beta brand first CosMx QX. allowing access month. cannot test emerging that customer to ship this technology Meanwhile, more while promote week, ecosystem portfolio, shipping begin are channel, to specifications companies this shipped seeking our entrants Earlier match partnership during to program. others drive brand two already our scores. other these generated
is to for is an AtoMx and storage Spatial to objective scalable and use that strategic image and cloud-based compute Platform. for first launch highly enables easy visualization, both Our CosMx analysis, GeoMx. Informatics AtoMx year solution our global collaboration, data the capacity
that of structure this biology ready to and important feedback that addressed showcased limited We machine launch approaches. the the AtoMx competitors. Research an uses In appreciated we and more fall. a and be learning was NanoString's datasets, artificial our portfolio meeting large flexible AtoMx outstanding. addition, during examined AtoMx and and managing was intelligence challenge of offerings using believe the anticipated AtoMx we provides differentiator We between spatial data during to customer plan AGBT
XXXX be both for franchise. is solution a collaborative Our can new is nCounter In for ROSALIND, nCounter analysis received, been data comprehensive our Pro, supports by growth that and we especially biopharma well and our These incorporates with business platform. which continued a have paired to customers. easily enhancements innovation. foundational fourth our channel cybersecurity objective global our a introduced April, sustain nCounter
We panels to of drive to continue outside adoption [cancer] new markets [ph]. and introduce
which nCounter channel, five collaboration this areas. the we developing integrating is our disease of and many launched leading our expand some disease for the This spatial of therapy cardiovascular are portfolio subject we'll a across most applications also and thought therapies gene the of institutions. application promising cell generation the These into now next We'll be considered platforms. quarter, for
call financial results our turn of the Now, the outlook. to I'd like over and details to review to Tom